Search

Owais Gul,1 Maria Khalid,1 Saqib Gul2 1Department of Internal Medicine, United Health Services Wilson Medical Center, Johnson City, NY, USA; 2Department of Medicine, Hamdard University, Karachi, PakistanCorrespondence: Owais Gul Department of Internal Medicine, United Health Services Wilson Medical Center, NY, USA, Tel +1 (607)-429-8737, Email owaisgul96@yahoo.com

Owais Gul,1 Saqib Gul,2 Abdul Aziz Godil3 1Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan; 2Department of Medicine, Hamdard University, Karachi, Pakistan; 3Department of Medicine, Jinnah Medical and Dental College, Karachi, PakistanWe read with great interest the recently published article “Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia” by Guzel et al.1 The study results are vital in understanding the variations among the levels of posterior pituitary neurohormones in patients with acute schizophrenia and seem to be of great value for future therapeutic modifications of the disease.View the original paper by Guzel and colleagues.

Owais Gul,1 Saqib Gul2 1Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan; 2Department of Medicine, Hamdard University, Karachi, PakistanWe read with great interest, the recently published article “Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment” by Albai et al.1 The article provided a great insight into evaluating the prevalence of mild cognitive impairment (MCI) in patients with type 2 diabetes (T2DM) and highlighted the risk factors for conversion of MCI to dementia. We would like to add some knowledge of the mechanisms and pathogenesis of the development of MCI in T2DM patients and a guide to possible future therapeutic developments.View the original paper by Albai and colleagues.